Trial By Error: My Follow-up Letter to Mahana Therapeutics ’ CEO

By David Tuller, DrPH Last week, I wrote to Rob Paull, the co-founder and CEO of Mahana Therapeutics, regarding the company’s misleading claims about the web-based cognitive behavior therapy program for irritable bowel syndrome it recently licensed from King’s College London. I have also written to Professor Rona Moss-Morris, the co-lead investigator of ACTIB, the […]
Source: virology blog - Category: Virology Authors: Tags: Uncategorized Source Type: blogs